Titan Biotech Share Price Rises 7.53% To ₹279.95 On Record Date For 1:5 Stock Split

Titan Biotech Limited (BSE: 524717) traded higher on Friday, February 20, 2026 the record date for its 1:5 equity share split with the stock quoting at ₹279.95, up ₹19.60 or 7.53% as of 9:51 AM IST.

The price movement comes on the day the sub-division of equity shares from face value ₹10 to ₹2 each takes effect for eligible shareholders, in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Dates and Timeline

The company had earlier informed exchanges on November 29, 2025 regarding the Board’s approval for the sub-division of equity shares. Shareholders approved the proposal via Postal Ballot on December 30, 2025.

February 20, 2026 was fixed as the record date to determine shareholders eligible for the split. Under the approved structure, 1 equity share of ₹10 each has been subdivided into 5 equity shares of ₹2 each, fully paid-up.

Purpose/Rationale Behind The Corporate Action

The stock split reduces the face value per share while proportionately increasing the number of outstanding equity shares.

The regulatory filing does not state additional strategic rationale. Such actions mechanically adjust the capital structure without altering the overall paid-up share capital of the company.

Impact On Shareholders

Pursuant to the 1:5 ratio, shareholders holding one equity share of ₹10 each as on the record date are entitled to receive five equity shares of ₹2 each.

The total face value of shareholding remains unchanged, while the number of shares held increases proportionately. The market price per share adjusts in line with the revised face value structure.

Market Snapshot & Share Price Effect

As of 9:51 AM IST on February 20, 2026, Titan Biotech shares were trading at ₹279.95 on the BSE, compared with the previous close of ₹260.35.

The stock opened at ₹288.35 and has so far touched a high of ₹290.00 and a low of ₹269.65 so far during the session. The 52-week high stands at ₹292.00, while the 52-week low is ₹74.73.

The company’s market capitalisation stands at ₹1,156.09 crore, with a free-float market capitalisation of ₹403.08 crore. Turnover during the session was approximately ₹1.11 crore, with traded quantity of 0.40 lakh shares. The stock is currently under ASM (Additional Surveillance Measure) Stage I, as per exchange classification.

Source:

• https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8da8e06-ace2-439b-bb4f-e0f2297c9254.pdf
• https://www.bseindia.com/stock-share-price/titan-biotech-ltd/TITANBIO/524717/